Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Watch for signs of domestic and global corporate health

Watch for signs of domestic and global corporate health this week

By Jenny Ruth

Sept. 23 (BusinessDesk) - While central banks on both sides of the Tasman will take centre stage downunder this week, there will also be plenty of information about corporate and economic health both domestically and globally.

Possibly of most significance for global growth will be the United States flash Performance of Manufacturing Index for September after the August reading of the Institute for Supply Management's PMI Index fell into contractionary territory for the first time since September 2009 in the wake of the global financial crisis.

US consumer spending accounts for two-thirds of the US economy which continues to chug along at a respectable rate of just above 2 percent, as does the New Zealand economy.

“It's the manufacturing side that looks pretty ugly, which is partly due to the trade tensions” between the US and China, says Mark Lister, the head of wealth research at Craigs Investment Partners.

“While that's a small part of the overall US economy, it does tell you things are fragile for a lot of sectors,” Lister says.

Late on Friday, news trickled out that Chinese officials, who were in the US to prepare for the resumption of high level trade talks early next month for the first time since April, returned to China earlier than scheduled after cancelling planned farm visits.

“There might not be anything in that, who knows whether it's relevant or not,” Lister says.

But financial markets took it as a signal to wind back their optimism that the two nations will be able to settle their differences soon.

Still, both sides were making positive noises over the weekend.

China’s state-run Xinhua news agency said on Saturday that fairly senior negotiators had “conducted constructive discussions” in Washington in recent days and had “agreed to continue to maintain communication.”

Meanwhile, a US statement called the discussions “productive” and said the US looks forward to welcoming the Chinese delegation for meetings in October.

PMIs for Europe and Japan will also be released on Monday and Tuesday – last month, these indices showed signs of improvement and stability.

On the home front, the corporate calendar is reasonably busy with Vector, Moa Group, Air New Zealand, Steel & Tube and Mercury New Zealand all holding their annual shareholders' meetings while retailers The Warehouse and Hallenstein Glassons and Fonterra will report their annual results.

Fonterra's results “will be closely watched, given the delays to this release, as well as the other issues facing the cooperative,” Lister says.

Fonterra had been due to report on Sept. 12 but said the week before that it and auditor PwC were still working through “significant accounting adjustments.”

The dairy giant did confirm prior guidance that it expects to report a loss of $590-675 million for the year to July 31, which is a 37-42 cent loss per share.

Lister says Air New Zealand's comments at its AGM on Wednesday will be worth watching.

“It's very tied into what's happening with tourism, which is very cyclical and economically sensitive and it's come off the boil recently,” he says.

“Air New Zealand tells us quite a lot about what's happening across the economy and further afield.”

The airline's take on the outlook for oil prices will also be worth taking note of following the attack on Saudi Arabia's production facilities.

Oil prices finished last week 6 percent higher, retracing much of the spike early in the week following the attack.

Lister says it's worth remembering that West Texas Intermediate crude oil was trading at US$72-73 a barrel this time last year compared with US$58 now.

As for that central bank action, Reserve Bank of Australia governor Philip Lowe will be delivering a speech on Tuesday with the title “An Economic Update” and is widely expected to greenlight another cut to his nation's cash rate following poor employment figures last week.

Market pricing of the likelihood of another 25 basis point cut to 0.75 percent jumped to 80 percent after the jobs report.

It will be the Reserve Bank of New Zealand's turn on Wednesday, although this will be a review of the official cash rate rather than a full monetary policy statement.

At the end of last week, the market pricing suggested just a 23 percent chance of an OCR cut following RBNZ's shock 50 basis point cut to 1 percent in early August.

But the chance of a cut at the next full monetary policy statement in November is priced at 74 percent and the chance of another cut in February next year is priced at 86 percent.



© Scoop Media

Business Headlines | Sci-Tech Headlines


Marine And Freshwater Reports: EDS Calls For Urgent Action On Marine Management

“There are some big issues to address. These include many marine species and habitats that are in serious trouble. Of the sample investigated, the report finds that 22% of marine mammals, 90% of seabirds and 80% of shorebirds are threatened with or actually at risk of extinction..." More>>


$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>


New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>


Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>